149 related articles for article (PubMed ID: 11982822)
1. Inflammation and cardiovascular risk in dialysis patients.
Wanner C; Zimmermann J; Schwedler S; Metzger T
Kidney Int Suppl; 2002 May; (80):99-102. PubMed ID: 11982822
[TBL] [Abstract][Full Text] [Related]
2. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.
Zimmermann J; Herrlinger S; Pruy A; Metzger T; Wanner C
Kidney Int; 1999 Feb; 55(2):648-58. PubMed ID: 9987089
[TBL] [Abstract][Full Text] [Related]
3. Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients.
Selim G; Stojceva-Taneva O; Zafirovska K; Sikole A; Gelev S; Dzekova P; Stefanovski K; Koloska V; Polenakovic M
Prilozi; 2006 Jul; 27(1):133-44. PubMed ID: 16985487
[TBL] [Abstract][Full Text] [Related]
4. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.
Yeun JY; Levine RA; Mantadilok V; Kaysen GA
Am J Kidney Dis; 2000 Mar; 35(3):469-76. PubMed ID: 10692273
[TBL] [Abstract][Full Text] [Related]
5. Both low and high serum ferritin levels predict mortality risk in hemodialysis patients without inflammation.
Shoji T; Niihata K; Fukuma S; Fukuhara S; Akizawa T; Inaba M
Clin Exp Nephrol; 2017 Aug; 21(4):685-693. PubMed ID: 27503345
[TBL] [Abstract][Full Text] [Related]
6. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease (CKD) 3-5 patients.
Soriano S; González L; Martín-Malo A; Rodríguez M; Aljama P
Clin Nephrol; 2007 Jun; 67(6):352-7. PubMed ID: 17598370
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis--role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up.
Bayés B; Pastor MC; Bonal J; Foraster A; Romero R
Nephrol Dial Transplant; 2006 Apr; 21(4):984-90. PubMed ID: 16326744
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients.
Liu SH; Li YJ; Wu HH; Lee CC; Lin CY; Weng CH; Chen YC; Chang MY; Hsu HH; Fang JT; Hung CC; Yang CW; Tian YC
PLoS One; 2014; 9(3):e93063. PubMed ID: 24667814
[TBL] [Abstract][Full Text] [Related]
10. CRP measurement: does the assay matter in hemodialysis patients?
Kanaan N; Goffin E; Maisin D; Struyven J; Jadoul M
Clin Nephrol; 2008 Dec; 70(6):503-7. PubMed ID: 19049707
[TBL] [Abstract][Full Text] [Related]
11. [Nutritional status, comorbidity, and inflammation in hemodialysis].
Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Vázquez A
Nefrologia; 2000; 20(6):540-9. PubMed ID: 11217649
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and inflammation in hemodialysis patients.
Spittle MA; Hoenich NA; Handelman GJ; Adhikarla R; Homel P; Levin NW
Am J Kidney Dis; 2001 Dec; 38(6):1408-13. PubMed ID: 11728983
[TBL] [Abstract][Full Text] [Related]
13. Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort.
Sasaki K; Shoji T; Kabata D; Shintani A; Okute Y; Tsuchikura S; Shimomura N; Tsujimoto Y; Nakatani S; Mori K; Shioi A; Inaba M; Emoto M
J Atheroscler Thromb; 2021 Mar; 28(3):249-260. PubMed ID: 32741893
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and malnutrition as predictors of mortality in patients on hemodialysis.
Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Díez JJ; Vázquez A
J Nephrol; 2002; 15(2):136-43. PubMed ID: 12018629
[TBL] [Abstract][Full Text] [Related]
16. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein is a strong predictor of mortality in hemodialysis patients.
Racki S; Zaputović L; Mavrić Z; Vujicić B; Dvornik S
Ren Fail; 2006; 28(5):427-33. PubMed ID: 16825093
[TBL] [Abstract][Full Text] [Related]
18. Association of malnutrition-inflammation score, dialysis-malnutrition score and serum albumin with novel risk factors for cardiovascular diseases in hemodialysis patients.
As'habi A; Tabibi H; Hedayati M; Mahdavi-Mazdeh M; Nozary-Heshmati B
Ren Fail; 2015 Feb; 37(1):113-6. PubMed ID: 25296104
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients: a 2-year prospective study.
Chauveau P; Level C; Lasseur C; Bonarek H; Peuchant E; Montaudon D; Vendrely B; Combe C
J Ren Nutr; 2003 Apr; 13(2):137-43. PubMed ID: 12671838
[TBL] [Abstract][Full Text] [Related]
20. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
